Cited by

• Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients.

  Pistone G, Pistone A, Sorbello D, Viviano E, Bongiorno MR. Pistone G, et al. Case Rep Dermatol. 2014 May 17;6(2):145-9. doi: 10.1159/000354030. eCollection 2014 May. Case Rep Dermatol. 2014. PMID: 24932169 Free PMC article.
• A prospective study of predictors of adherence to combination antiretroviral medication.

  Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH, Wenger NS. Golin CE, et al. J Gen Intern Med. 2002 Oct;17(10):756-65. doi: 10.1046/j.1525-1497.2002.11214.x. J Gen Intern Med. 2002. PMID: 12390551 Free PMC article.
• How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

  Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, Ma Y, Kaplan AH, Wenger NS. Miller LG, et al. J Gen Intern Med. 2002 Jan;17(1):1-11. doi: 10.1046/j.1525-1497.2002.09004.x. J Gen Intern Med. 2002. PMID: 11903770 Free PMC article.
• Factors associated with good glycemic control among patients with type 2 diabetes mellitus.

  Ahmad NS, Islahudin F, Paraidathathu T. Ahmad NS, et al. J Diabetes Investig. 2014 Sep;5(5):563-9. doi: 10.1111/jdi.12175. Epub 2013 Dec 5. J Diabetes Investig. 2014. PMID: 25411625 Free PMC article.
• Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients.

  Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E. Perrone V, et al. Clinicoecon Outcomes Res. 2014 Jul 14;6:341-8. doi: 10.2147/CEOR.S58036. eCollection 2014. Clinicoecon Outcomes Res. 2014. PMID: 25053888 Free PMC article.